Browsing by Author le Roux, Carel W.

Showing results 1 to 16 of 16
Published DateTitleAuthor(s)
Dec-2020Can Metabolic Surgery Be Used to Improve Access to and Outcomes of Kidney Transplantation?Martin, William P.le Roux, Carel W.
2-Aug-2020Characterization of the renal cortical transcriptome following Roux-en-Y gastric bypass surgery in experimental diabetic kidney diseaseNair, MeeraMartin, William P.Zhernovkov, VadimElliott, JessieFearon, NaomiEckhardt, HansMcCormack, JanetGodson, CatherineBrennan, EoinFandriks, LarsDocherty, Neil G.le Roux, Carel W.
Feb-2020Comment on: Impact of serum uric acid on renal function after bariatric surgery: a retrospective studyMartin, William P.le Roux, Carel W.
1-Jun-2019Comment on: Metabolic surgery improves renal injury independent of weight loss: a meta-analysisMartin, William P.le Roux, Carel W.
Jul-2018How Ethical Is Our Current Delivery of Care to Patients with Severe and Complicated Obesity?Craig, Hilaryle Roux, Carel W.Keogh, FionaFinucane, Francis M.
19-Sep-2018Impact of bariatric surgery on cardiovascular and renal complications of diabetes: a focus on clinical outcomes and putative mechanismsMartin, William P.Docherty, Neil G.le Roux, Carel W.
Feb-2021The Impact of CKD on Perioperative Risk and Mortality after Bariatric SurgeryCarvalho Silveira, FlaviaMartin, William P.Maranga, Gabriellele Roux, Carel W.Ren-Fielding, Christine J.
Oct-2019Impact of intentional weight loss on diabetic kidney diseaseHolland, John A.Martin, William P.Docherty, Neil G.le Roux, Carel W.
Nov-2021Impact of Metabolic Surgery on Renal Injury in Pre-Clinical Models of Diabetic Kidney DiseaseMartin, William P.le Roux, Carel W.Docherty, Neil G.
26-Jan-2022Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney DiseaseMartin, William P.Chuah, Yeong H. D.Abdelaal, MahmoudHutter, MichaelaGodson, CatherineBrennan, Eoinle Roux, Carel W.Docherty, Neil G.et al.
17-Aug-2020Metabolic Surgery to Treat Obesity in Diabetic Kidney Disease, Chronic Kidney Disease, and End-Stage Kidney Disease; What Are the Unanswered Questions?Martin, William P.White, JamesLópez-Hernández, Francisco J.Docherty, Neil G.le Roux, Carel W.
Dec-2020Obesity is common in chronic kidney disease and associates with greater antihypertensive usage and proteinuria: evidence from a cross-sectional study in a tertiary nephrology centreMartin, William P.Bauer, JessicaColeman, JohnDellatorre-Teixeira, LudmillaReeve, Janice L. V.Twomey, Patrick J.Docherty, Neil G.O'Riordan, AislingWatson, Alan J.le Roux, Carel W.Holian, John
9-Sep-2020Parallel assessment of albuminuria and plasma sTNFR1 in people with type 2 diabetes and advanced chronic kidney disease provides accurate prognostication of the risks of renal decline and deathMartin, William P.Tuohy, ColmDoody, AlisonJackson, SabrinaCanavan, Ronan J.Slattery, DavidTwomey, Patrick J.McKenna, Malachi J.le Roux, Carel W.Docherty, Neil G.
15-Nov-2021Protocol for a preclinical systematic review and meta-analysis of pharmacological targeting of peroxisome proliferator-activated receptors in experimental renal injuryMartin, William P.Chuah, Yeong H. D.Conroy, EmerReynolds, AlisonJudge, ConorLópez-Hernández, Francisco J.le Roux, Carel W.Docherty, Neil G.
2-Feb-2022Urinary Metabolomic Changes Accompanying Albuminuria Remission following Gastric Bypass Surgery for Type 2 Diabetic Kidney DiseaseMartin, William P.Malmodin, DanielPedersen, AndersWallace, Martinale Roux, Carel W.Docherty, Neil G.et al.
18-Sep-2017Validating the association between plasma tumour necrosis factor receptor 1 levels and the presence of renal injury and functional decline in patients with Type 2 diabetesDoody, AlisonJackson, SabrinaElliott, JessieGodson, Catherinele Roux, Carel W.Docherty, Neil G.et al.